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The Ubiquitin Proteasome System Acutely Regulates
Presynaptic Protein Turnover and Synaptic Efficacy
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degradation by the proteasome or endocytosis and traf-
ficking to the lysosomal pathway. The tightly regulated
Summary cascade controlling protein degradation via the protea-
some has pivotal regulatory roles in a wide spectrum of
Background: The ubiquitin proteasome system (UPS) cellular processes, ranging from cell cycle control to
mediates regulated protein degradation and provides a modulation of the immune response. Therefore, it is sur-
mechanism for closely controling protein abundance in prising that little work has been done to investigate puta-
spatially restricted domains within cells. We hypothe- tive functional roles of the (UPS) in the mature nervous
sized that the UPS may acutely determine the local con- system, particularly in the regulation of the complex
centration of key regulatory proteins at neuronal syn- protein cycles that acutely modulate the efficacy of syn-
apses as a means for locally modulating synaptic aptic transmission.
efficacy and the strength of neurotransmission commu- Recent work has begun to reveal roles for ubiquitin-
nication. dependent processes in neuronal development, espe-
Results: We investigated this hypothesis at the Dro- cially during synapse formation and modulation. In Dro-
sophila neuromuscular synapse by using an array of sophila, ubiquitin conjugation triggers the endocytosis
genetic and pharmacological tools. This study demon- of signaling proteins with key guidance functions in axo-
strates that UPS components are present in presynaptic nal pathfinding [1]. At the Drosophila neuromuscular
boutons and that the UPS functions locally in the presyn- junction (NMJ), both functional and anatomical synaptic
aptic compartment to rapidly eliminate a conditional development is regulated by a balance between ubiqui-
transgenic reporter of proteasome activity. We assayed tylation and de-ubiquitylation [2]. Recent studies of C.
a panel of synaptic proteins to determine whether the elegans central synapses have shown that ubiquitin is
UPS acutely regulates the local abundance of native also involved in the endocytosis and possible degrada-
synaptic targets. Both acute pharmacological inhibition tion of the glutamate receptor subunit GLR-1 at postsyn-
of the proteasome (1 hr) and targeted genetic pertur- aptic sites [3].The authors propose that this mechanism
bation of proteasome function in the presynaptic neuron may regulate the strength of synaptic transmission; mu-
cause the specific accumulation of the essential synap- tations that decrease GLR-1 ubiquitylation also increase
tic vesicle-priming protein DUNC-13. Most importantly,
locomotory activity. These Drosophila and C. elegans
acute pharmacological inhibition of the proteasome (1
studies clearly demonstrate that ubiquitin-dependent
hr) causes a rapid strengthening of neurotransmission
mechanisms play vital roles in synapses, most particu-
(an approximately 50% increase in evoked amplitude)
larly in regulating endocytosis to control protein traffick-because of increased presynaptic efficacy. The pro-
ing to and from the plasma membrane. However, theteasome-dependent regulation of presynaptic protein
direct involvement of proteasomal protein degradationabundance, both of the exogenous reporter and native
in regulating these synaptic mechanisms is unclear.DUNC-13, and the modulation of presynaptic neuro-
In addition to developmental functions, the UPS hastransmitter release occur on an intermediate, rapid (tens
also been implicated in the manifestation of long-termof minutes) timescale.
synaptic plasticity. Recent studies in Aplysia synapsesConclusions: Taken together, these studies demon-
have demonstrated that transition from short-term facili-strate that the UPS functions locally within synaptic bou-
tation (STF) to long-term facilitation (LTF) depends ontons to acutely control levels of presynaptic protein and
proteasome-mediated protein degradation [4]. Similarly,that the rate of UPS-dependent protein degradation is
in rat synapses the transition from short-term potentia-a primary determinant of neurotransmission strength.
tion (STP) to long-term potentiation (LTP) requires UPS
function in the hippocampus [5]. Null mutations in theIntroduction
E3 ubiquitin ligase E6-AP prevent this synaptic plasticity
transition in mouse hippocampal neurons [6]. To date,The attachment of ubiquitin to substrate proteins is ac-
only a few synaptic proteins have been identified ascomplished via a regulated cascade of enzymes begin-
substrates of ubiquitin attachment; -synuclein [7], syn-
philin [8], and CDCrel-1 [9] are ubiquitylated by the ubi-Correspondence: kendal.broadie@vanderbilt.edu
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Figure 1. Components of the UPS Are Present in Presynaptic Boutons
(A) Depiction of the enzyme cascade responsible for ubiquitylation and degradation of UPS substrates.
(B) Representative Western blots of the Drosophila brain with antibodies against the human ubiquitin-activating enzyme (E1) and 20s protea-
some. Both antibodies crossreact with a single intense band corresponding to the size of the Drosophila E1 and a 20s subunit, respectively.
(C) Confocal projections of single Drosophila NMJ terminals demonstrate colocalization of E1 and the 20s proteasome subunit immunoreactivity
with the presynaptic marker, synaptic vesicle-associated Cysteine String Protein (CSP). Abbreviations are as follows: synaptic boutons (sb),
nerve (n), and muscle (m). The scale bar indicates 10 M.
quitin ligase Parkin. It has also been demonstrated that synaptic target proteins in vivo, and the functional role
of the UPS in controlling synaptic efficacy. For thesethe synaptic vesicle protein, synaptophysin, is ubiqui-
tylated and degraded by the proteasome [10]. Very re- studies, we used genetic and pharmacological methods
to manipulate UPS-mediated protein turnover at thecently, it was shown that activity-dependent remodeling
of the postsynaptic density is regulated via ubiquitin Drosophila NMJ synapse and monitored the effects with
electrophysiology and confocal microscopy. Investiga-and proteasomal degradation [11], albeit on a relatively
slow timescale (about 48 hr). These studies clearly dem- tions with a conditional reporter of ubiquitin-mediated
proteolysis demonstrate local UPS-dependent proteinonstrate critical functions for the UPS in mature syn-
apses, with direct UPS involvement in regulating the degradation at the synapse and indicate that the UPS
has the capacity to degrade highly expressed presynap-abundance of synaptic proteins. However, no studies
have investigated interactions of putative presynaptic tic proteins. Pharmacological and genetic inhibition of
the proteasome show that protein degradation rate de-substrates with the UPS or determined whether these
interactions acutely regulate synaptic transmission termines the local abundance of DUNC-13, a protein
that regulates synaptic vesicle priming to control neuro-strength.
Does the UPS directly regulate presynaptic protein transmission strength [12, 13]. Concurrent work in our
lab demonstrates that DUNC-13 is ubiquitylated [14].levels to modulate neurotransmission? In answering this
question, our key tasks were to investigate the presence Most interestingly, acute inhibition of the proteasome
causes a dramatic strengthening of synaptic transmis-of the UPS locally at presynaptic sites, the kinetic capac-
ity of the UPS to regulate protein abundance at these sion that is rapid (tens of minutes) and presynaptic in
nature. Taken together, these results demonstrate thatsites, putative interactions between the UPS and pre-
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the UPS functions to regulate the local abundance of recognized by the UPS and remain stable at 35C. In
contrast, R-DHFRts-EGFP will expose its N-terminal argi-presynaptic proteins and that through this local mecha-
nism it acutely modulates the strength of synaptic trans- nine at 35C and be recognized by the ubiquitin ligase
Ubr1 (E3), which acts with the ubiquitin-conjugatingmission.
enzyme (E2; Rad6 [23]) to ubiquitylate N-end rule sub-
strates on an internal lysine residue. Drosophila has bothResults
a Ubr1 and Rad6 homolog, encoded by CG9086 (22%
identical/44% similar) and Dhr6 (68% identical/85% sim-UPS Components Present at the Synapse
ilar), respectively. It has been demonstrated in yeastIn order to assess whether UPS-mediated protein turn-
that R-DHFRts fused to a protein of interest will directover occurs locally at the Drosophila NMJ synapse, we
its degradation via the proteasome in response to thefirst analyzed the subcellular distribution of UPS compo-
18C→35C temperature shift [21]. We employed thisnents. The ubiquitin-activating enzyme (E1) and the 26s
yeast heat-inducible degron system here to assay UPS-proteasome are the beginning and the end, respectively,
mediated protein degradation at the Drosophila NMJof the UPS enzymatic cascade (Figure 1A). Antibodies
synapse.against human E1 [15] and the 20s [16] core proteasome
M-DHFRts-EGFP and R-DHFRts-EGFP reporter pro-particle each recognize a single protein of the predicted
teins were driven in the Drosophila nervous system bysize of Drosophila E1 and a Drosophila 20s proteasome
the GAL4:UAS system [24], and protein expression wassubunit, respectively (Figure 1B). Confocal microscopy
monitored via native EGFP fluorescence. Both fusionassays demonstrate that both proteins are present at
proteins expressed well in the nervous system and werethe mature third-instar Drosophila NMJ (Figure 1C). Note
present in NMJ presynaptic boutons maintained atthat both the E1 ubiquitin-activating enzyme and the
18C (Figure 2A). In sharp contrast, a 30 min heat shockproteasome are present in the cell bodies and peripheral
at 35C initiated turnover of presynaptically expressedaxons of motor neurons and are distributed throughout
R-DHFRts-EGFP (Figures 2A and 2B). Conversely, boththe syncitial muscle. In addition, however, both proteins
the control EGFP and M-DHFRts-EGFP protein levelsare present within synaptic boutons at the NMJ, where
remained stable at 35C, with no significant loss of pro-they colocalize with presynaptic markers of synaptic
tein expression (Figures 2A and 2B). Quantitative fluo-vesicle pools (e.g., synaptic vesicle-associated protein
rescence confocal microscopy of protein abundance inCysteine String Protein (CSP); Figure 1C). In addition to
presynaptic boutons after 30 min at 35C demonstratedthese results, ubiquitin conjugates have been detected
that50% of R-DHFRts-EGFP had been degraded com-in synaptic membrane preparations [17, 18] and ubiqui-
pared to3% of M-DHFRts-EGFP under identical condi-tin immunoreactivity is present at the human NMJ [19].
tions (Figure 2B).These data suggest that both the attachment of ubiquitin
The next aim was to determine whether the loss ofto substrate proteins and the subsequent degradation
fluorescent reporter protein expression at the NMJ syn-of the ubiquitylated proteins by the proteasome may
apse represented protein degradation, as predicted.occur locally at presynaptic sites of neurotransmitter
This was accomplished by determination of the amountrelease.
of the R-DHFRts-EGFP and M-DHFRts-EGFP fusion pro-
teins via Western analyses of nervous system extracts
UPS-Mediated Protein Degradation from animals maintained at the permissive temperature
at the Synapse (18C) or placed for 30 min at the restrictive temperature
To investigate whether local protein turnover occurs at (35C) (Figure 2C). Western analyses confirmed that both
the synapse, we used a conditional substrate of a well- the R-DHFRts-EGFP and M-DHFRts-EGFP proteins are
characterized UPS pathway (termed the “N-end rule”) stably expressed at 18C in the nervous system. How-
to assay protein degradation [20]. The conditional UPS ever, in response to the 35C heat shock, the R-DHFRts-
substrate (termed a “heat-inducible degron” [21]) was EGFP protein was degraded to nearly undetectable lev-
fused to a Hemaglutanin (HA)-tagged enhanced Green els within 30 min, whereas the M-DHFRts-EGFP protein
Fluorescent Protein (EGFP) to permit both immunologi- was maintained at similar levels at both 18C and 35C
cal and fluorescent assays of protein levels. The heat- (Figure 2C). These results confirm that the loss of fluo-
inducible degron is a thermolabile version of dihydrofo- rescence protein expression in in vivo synapses repre-
late reductase (DHFRts) that was developed in yeast; at sents UPS-specific protein degradation.
18C the protein is stable, but at higher temperature To determine whether ubiquitylation signals local pro-
(35C) it undergoes a conformational change to become tein degradation at the synapse, we applied the drug
a substrate of N-end rule enzymes, and the protein is methotrexate (MTX) to R-DHFRts-EGFP-expressing NMJ
ubiquitylated and rapidly degraded by the 26s protea- terminals. MTX has been shown to stabilize R-DHFRts
some. The N-end rule, as elucidated in yeast, states that at nonpermissive temperatures by blocking degradation
the half-life of a protein is determined by its N-terminal by the proteasome, but MTX does not block the attach-
residue [22]; an N-terminal methionine acts as a stabiliz- ment of ubiquitin to the substrate protein [25]. In yeast,
ing residue, whereas an N-terminal arginine acts as a MTX binding to R-DHFRts stops its degradation by pre-
destabilizing residue, conferring a short half-life on a venting unfolding and threading of the protein into the
protein. In this study, two versions of DHFRts fused to catalytic barrel of the proteasome, a requirement for
GFP were employed; one with an N-terminal methionine proteolytic cleavage [26, 27]. Treatment with MTX com-
(M-DHFRts-EGFP) and a second with an N-terminal argi- pletely blocked the rapid degradation of R-DHFRts-EGFP
observed during heat shock at 35C (Figures 2A andnine (R-DHFRts-EGFP). The M-DHFRts-EGFP will not be
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Figure 2. N-End Rule-Mediated Protein Degradation Occurs Locally in Presynaptic Boutons
(A) R-DHFRts-HA-EGFP, a conditional reporter of the N-end rule pathway of degradation, and M-DHFRts-HA-EGFP, an internal control reporter,
were expressed under UAS control in the presynaptic terminal of wandering third-instar larvae NMJs (see text for details). The panels show
representative confocal projections of single NMJs before and after a 30 min heat shock (35C). The conditionally ubiquitylated R-DHFRts-
HA-EGFP protein was specifically eliminated from the synapse, whereas all controls were unaffected.
(B) Graph showing the percentage of protein fluorescence left at synaptic boutons after a 30 min heat shock. M-DHFRts-EGFP fluorescence
was maintained (97%  27; n  8; no significant change), whereas R-DHFRts-EGFP fluorescence was strongly reduced (50%  13; n  16;
P  0.0001). Introduction of methotrexate (MTX) blocked the loss of R-DHFRts-EGFP fluorescence (86%  15; n  9; no significant change).
All reported statistics are normalized with respect to UAS:EGFP values.
(C) A representative Western blot demonstrates that R-DHFRts-HA-EGFP was degraded in the Drosophila nervous system in response to a
30 min heat-shock at 35C. The level of M-DHFRts-HA-EGFP was unchanged under identical conditions. Anti-leonardo was used as a control
for levels of synaptic proteins.
(D) Time course experiment of R-DHFRts-EGFP degradation at the NMJ. The synapse was imaged, subject to a 30 min heat shock (35C), and
then imaged at each labeled time point to quantify the rate of protein degradation. The predicted curve (dotted) was generated with the
experimentally determined half-life of the protein with the half-life equation to calculate the percent fluorescence remaining if one assumes
exponential decay.
2B). In the presence of MTX, R-DHFRts-EGFP abundance not removed from the terminal via retrograde transport
but rather are locally degraded by the proteasome withinwas not significantly altered relative to the inactive
M-DHFRts-EGFP construct (Figure 2B). These results synaptic boutons.
Time course assays of protein degradation rate weredemonstrate that ubiquitylated presynaptic proteins are
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next performed to determine the kinetics of UPS-medi- dance on this timescale of1 hr (Figures 3A and 3B). All
other synaptic proteins assayed showed no significantated protein turnover in the in vivo presynaptic terminal.
Animals expressing R-DHFRts-EGFP in singly identified changes in protein levels in response to lactacystin
treatment (Figures 3A and 3B). Additionally, the level ofpresynaptic terminals were imaged, subjected to a 30
min heat shock at 35C, and then reimaged at the indi- cysteine string protein (CSP) was not altered in response
to proteasome inhibition [14].The level of DUNC-13 ascated time by fluorescent confocal microscopy. In Fig-
ure 2D, the predicted degradation curve (half-life of 30 measured by confocal analysis in single synaptic bou-
tons was increased approximately 2-fold, a highly signif-min) of a protein with a destabilizing N-terminal arginine
residue is shown relative to the observed abundance icant (P  0.001) elevation in protein abundance. Com-
bined, these results indicate that the level of presynapticof R-DHFRts-EGFP imaged at the NMJ synapse. The
predicted and observed protein abundance curves cor- proteins in general is not under dynamic regulation via
the proteasome on the timescale assayed (approxi-relate closely; at 30 min the protein was at about 50%
of starting levels, and at 60 min the protein was at ap- mately 1 hr), but rather that DUNC-13 shows specific,
UPS-dependent regulation at the synapse.proximately 25% of starting levels (Figure 2D). However,
the synaptic abundance of R-DHFRts-EGFP remained
level from 60 to 150 min, at 15%–20%of starting levels.
Genetic Inhibition of the Proteasome CausesThus, degradation of the reporter initially followed the
Accumulation of DUNC-13predicted decay curve but reached an asymptote at low
To complement the pharmacological method using lac-protein levels. The low level of persisting protein may
tacystin, an independent genetic approach was nextreflect the fact that the inducing 35C heat-shock was
used to further investigate the UPS dependence ofremoved at 30 min, some inherent limitation to the fluo-
DUNC-13 abundance at the synapse. Specifically, a tar-rescent assay method, or saturation of the UPS at the
geted genetic mutation of a proteasome subunit wassynapse under these demanding transgenic conditions.
employed to interfere with 26s proteasome function onlyThese data demonstrate that the N-end rule of ubiquitin-
in the presynaptic neuron. The 26s proteasome is amediated protein degradation functions locally at the
multisubunit complex composed of a core catalytic 20sDrosophila NMJ synapse and regulates protein abun-
particle and 19s regulatory particles capping either enddance on an intermediate timescale (half-life of tens of
of the core. The catalytic activity of the 20s core isminutes).
housed in the -subunit rings, in particular the 1, 2,
and5 subunits. Drosophila dominant temperature-sen-
sitive (DTS) mutants have been isolated in the 6 andNative Synaptic Protein Targets of the UPS
Components of the UPS are present in presynaptic ter- 2 subunits [29, 30]. Genetic analyses have shown that
these mutants act as antimorphs to disrupt proteasomeminals of the Drosophila NMJ, and the UPS functions
locally in presynaptic boutons to mediate proteasome- function to varying degrees at all temperatures [30–34].
The DTS5 mutation utilized in these experiments dis-dependent protein degradation. Recent work in our lab
has shown that the levels of the synaptic protein DUNC- rupts a 6 subunit residue that is required for formation
of the catalytic active site. The DTS5 mutant subunit13 appear to be controlled via proteasome-mediated
degradation [14]. These observations suggest that UPS- under UAS control was expressed in the presynaptic
motor neuron of the NMJ via the pan-neuronal Elav GAL4mediated protein degradation may play a dynamic role
in regulating the abundance of presynaptic proteins driver.
Immunocytochemical analyses were done on singlecontrolling neurotransmission strength or plasticity. If
this is the case, then we wanted to determine whether NMJ synapses of wandering third-instar larvae (Figure
3C). Two separate insertions of the UAS:DTS5 transgeneall synaptic proteins are dynamically regulated via pro-
teasome-mediated degradation or whether this mecha- [DTS5(2B) and DTS5(6A)] produced significantly ele-
vated levels of DUNC-13 when expressed in the presyn-nism is specific to a class of key synaptic proteins. To
address this question, we used a highly specific protea- aptic neuron at 18C. A single copy of DTS5(2B) caused
an extremely significant (P  0.0001) 56% increase insome inhibitor, lactacystin [28], to acutely disrupt UPS
function, then assayed synapses for the abundance of the levels of DUNC-13 in the NMJ terminal (Figures 3C
and 3D). Although a single copy of DTS5(6A) did notknown presynaptic proteins via quantitative fluores-
cence confocal microscopy. Specific antibody probes significantly increase DUNC-13 levels, an additional
copy of the DTS5(6A) insert caused a significant (P are available for multiple classes of presynaptic pro-
teins, including transmembrane, membrane-associated 0.05) elevation (23%) of DUNC-13 levels in presynaptic
boutons (Figures 3C and 3D). The difference in effectiveand cytosolic components of the presynaptic terminal.
Dissected third-instar larvae were incubated in either concentration of DTS5(2B) and DTS5(6A) most probably
reflect position effects of the transgene genomic inser-control saline or in the presence of lactacystin (100 	M)
for 45 min prior to immunocytochemical analyses. Anti- tions and are consistent with the observation that, com-
pared to DTS5(2B), the DTS5(6A) insert causes a lessbody probes against presynaptic proteins used in this
survey analysis included Syntaxin (transmembrane), severe phenotype in the eye [31]. These results confirm
the pharmacological evidence that DUNC-13 is a sub-Synaptotagmin (integral synaptic vesicle), Leonardo/14-
3-3
 (cytosolic), and DUNC-13 (cytosolic). Among these strate of the UPS and further demonstrate that the abun-
dance of DUNC-13 in the presynaptic bouton is regu-possible targets of UPS regulation, only DUNC-13A
showed any significant change in presynaptic abun- lated by its degradation rate.
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Figure 3. Pharmacological and Genetic Disruption of the Proteasome Rapidly Increases DUNC-13A Abundance at the Synapse
(A) Representative confocal projections of synaptic boutons of third-instar larvae costained for anti-HRP and anti-DUNC-13A after 45 min
incubation in the absence or presence of lactacystin, a specific proteasome inhibitor. The abundance of DUNC-13A was qualitatively elevated
after proteasome inhibition, whereas the level of other presynaptic proteins did not change (not shown).
(B) Graph showing quantified fluorescence ratios between presynaptic proteins and anti-HRP (internal control) in the absence and presence
of lactacystin. A 95% increase (P  0.0001; n  152) in the levels of DUNC-13 were detected, whereas no significant change was detected
for other presynaptic proteins assayed: syntaxin (n 150), synaptotagmin (n 172), and leonardo (n 150). Ratios are normalized to untreated
controls; n represents the number of single bouton assayed.
(C) Representative confocal projections of anti-DUNC-13A and anti-HRP staining in synaptic boutons of the indicated proteasome mutant
genotypes. The abundance of DUNC-13A was qualitatively elevated after genetic inhibition of the proteasome at 18C.
(D) Graph of the quantified fluorescence intensity ratios of DUNC-13A/HRP in the indicated genotypes. 56% (P  0.001) and 23% (P  0.05)
increases in DUNC-13A levels were seen in Elav/;DTS5(2B)/ and Elav/;DTS5(6A)/DTS5(6A) animals, respectively, in comparison to Elav/
controls (Elav/ 1.11  0.06 [n  23], Elav/;DTS5(2B)/ 1.69  0.09 [n  12], Elav/;DTS5(6A)/DTS5(6A) 1.35  0.10 [n  12]). Fluorescence
ratios were obtained blind; a single ‘n’ represents a single NMJ and all its boutons.
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Figure 4. Proteasome Inhibition Rapidly Ele-
vates Presynaptic Transmission Efficacy
(A) Average amplitude of evoked excitatory
junctional current (EJC) synaptic transmis-
sion events after 45 min incubation in the pro-
teasome inhibitors lactacystin and epoxi-
mycin. Controls include standard saline or
saline  DMSO (control). Mean EJC ampli-
tude in control saline was 44.24/ 6.26 (n
8) versus lactacystin-treated 70.06  6.05
(n  9), which represents a highly significant
(P  0.01) elevation in transmission. For
saline  DMSO, mean EJC amplitude was
55.84  5.35 (n  9) versus 77.95  7.53
(n 9) for epoxomicin-treated animals, which
represents a significant (P 0.0293) increase
in transmission.
(B) Representative EJC traces recorded from
control and lactacystin-treated animals.
(C) Representative sweep of spontaneous
miniature EJC (mEJC) events recorded from
control and lactacystin-treated animals.
(D) A graph of average mEJC amplitude in
control and lactacystin-treated animals
showed no significant differences (saline:
0.612  0.029, n  8; lactacystin: 0.657 
0.050, n  8; saline  DMSO: 0.632  0.077,
n  8; and epoxomicin: 0.622  0.041, n  8.
(E) Graph of mEJC frequency in control and
lactacystin-treated animals (saline: 1.72 
0.114, n  8; lactacystin: 1.79  0.453, n 
8; and saline  DMSO: 2.67  0.425, n  8.
Proteasome Inhibition Causes Rapid epoxomicin, when the mean EJC amplitude in DMSO
control animals was 55.84  5.35 compared to 77.95 Strengthening of Synaptic Transmission
Previous work in Xenopus and chromaffin cells suggests 7.53 (P  0.0293) in epoxomicin-treated animals. In-
vestigation of spontaneous miniature EJC (mEJC) ampli-that the levels of UNC-13 homologs are crucial for de-
termining the extent of synaptic vesicle priming and thus tudes showed similar values in controls versus lactac-
ystin- or epoxomicin-treated NMJ terminals (Figures 4Cthe strength of neurotransmission [12, 13]. In particular,
presynaptic overexpression of MUNC13-1 at the Xeno- and 4D). These data indicate that the elevated evoked
EJC amplitude in lactacystin- and epoxomicin-treatedpus NMJ causes an increase in transmitter release [12].
Similarly, overexpression of MUNC13-1 in chromaffin synapses must be due to increased presynaptic trans-
mitter release. Interestingly, no significant change wascells increases dense core vesicle exocytosis [13].
These results coupled with our findings in this paper seen in mEJC frequency in lactacystin- or epoxomicin-
treated animals in comparison to controls (Figure 4E).predict that synaptic transmission may be elevated in
response to proteasome inhibition. To test this hypothe- Thus, acute inhibition of the proteasome causes an in-
crease in presynaptic neurotransmitter release specific tosis, we used the proteasome inhibitors lactacystin and
epoxomicin [35–37] to acutely disrupt UPS function the evoked neurotransmission mechanism (Figures 4A
and 4B).while monitoring synaptic transmission at the Drosoph-
ila NMJ in a two-electrode voltage clamp (TEVC) re- In principle, either the proteasome inhibitor lactacys-
tin or epoxomicin could interfere with neuronal functioncording configuration.
Dissected third-instar larvae were incubated in either in multiple ways. One could imagine that inhibition of
the proteasome could lead to the stabilization of tran-control saline, DMSO carrier, lactacystin (100 M), or
epoxomicin in DMSO (125 M) for 45 min prior to wash- scription factors responsible for activation of synaptic
genes and thereby increase the synthesis of synapticing with control saline and TEVC recording. During this
interval, control animals maintained constant amplitude proteins crucial for transmission. Such a transcriptional
mechanism appears unlikely in the present study givenexcitatory junctional current (EJC) amplitudes, whereas
both lactacystin- and epoxomicin-treated animals dis- that the motor axon was left intact for only approximately
30 min prior to being cut for the electrophysiologicalplayed strikingly increased EJC amplitudes (Figures 4A
and 4B). When the proteasome was inhibited, EJC am- recordings. It seems unlikely that transcriptional activa-
tion, protein translation, and transport to the NMJ syn-plitude increased by an average of about 50% in 1 hr.
Under recording conditions, the mean EJC amplitude in apse could happen in this short timespan. However,
another possibility is an upregulation of translation ofcontrol animals was 44.24  6.26 compared to 70.06 
6.05 in lactacystin-treated animals, a highly significant mRNAs preexisting at the terminal. There is evidence of
local translation occurring in axons and synapses [38].(P  0.0096) increase in neurotransmission strength
(Figures 4A and 4B). Similar results were obtained with Therefore, to conclusively determine whether changes
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in transcription and/or translation could account for the termining neurotransmission strength. We investigated
these questions at the Drosophila NMJ by using a com-observed increase in neurotransmission, we repeated
recordings with the proteasome inhibitor epoxymicin bination of genetic and pharmacological tools to manip-
ulate UPS activity while assaying consequences with(125M) coapplied together with the translational inhibi-
tor anisomycin (40M). Application of this concentration immunocytological and electrophysiological methods at
the in vivo synapse.of anisomysin to synaptic terminals has been shown to
completely inhibit translation [39]. Translation inhibition This study shows that both the beginning (ubiquitin-
activating enzyme E1) and end (26s proteasome) of thedid not prevent the rapid elevation of synaptic transmis-
sion after proteasome inhibition. EJC amplitude after UPS enzymatic cascade are present in the presynaptic
terminal. By employing a transgenic reporter of UPScoapplication of epoxymicin and anisomycin (n  6)
was 70.57  8.46 nA compared to 42.71  7.13 for activity (R-DHFRts-EGFP), which is conditionally ubiqui-
tylated in a temperature-dependent manner, this studyanisomycin alone (n  6), a significant (P  0.0152)
increase of transmission amplitude caused by protea- demonstrates conclusively that ubiquitin-mediated pro-
tein degradation occurs locally at presynaptic sites.some inhibition in the absence of transcription activa-
tion. These results indicate that the UPS plays a role Substitution of a single amino acid in the transgenic
reporter to remove the ligase binding site (M-DHFRts-locally at presynaptic release sites to acutely regulate
the strength of neurotransmission. EGFP) completely eliminates its induced degradation,
proving the specificity of the UPS-dependent protein
degradation at the synapse. Use of the drug methotrex-
Discussion ate, which blocks proteasome degradation but not
R-DHFRts-EGFP ubiquitylation [25], demonstrated that
A great deal of investigation has focused on the roles ubiquitylated R-DHFRts-EGFP is not retrogradely trans-
of transcription, translation, protein transport, and post- ported from the synaptic terminal, but rather is proteolyt-
translational modification (e.g., phosphorylation) in the ically degraded locally. Kinetic assays of protein degra-
regulation of neurotransmission strength, particularly dation rate indicate that at least 50% of the abundant,
during activity-dependent synaptic plasticity. Although conditionally ubiquitylated protein is degraded in pre-
these mechanisms are undoubtedly involved in the regu- synaptic boutons within 30 min and that80% of protein
lation of synaptic efficacy, an intriguing new idea is that is eliminated within 1 hr. Taken together, these results
the effective abundance of key regulatory synaptic pro- demonstrate clearly that the UPS has the capacity to
teins may be determined by their rate of local degrada- modulate the local levels of even highly expressed pre-
tion. This hypothesis suggests that protein turnover may synaptic proteins.
be dynamically regulated by local signals (e.g., G protein The conditional UPS reporter R-DHFRts-EGFP is a
regulatory cascades) that tag proteins for ubiquitylation specific substrate of “N-end rule” proteasomal degrada-
and thus trigger their rapid degradation via the 26s pro- tion [45]. These studies therefore demonstrate that the
teasome. Despite the fact that actively regulated protein N-end rule pathway of degradation functions at the syn-
degradation is a well-established control mechanism in apse. Interestingly, inactivation of the asparagine-spe-
numerous biological processes (e.g., cell cycle control), cific N-terminal amidase (NTAN1), a gene functioning in
the role of protein degradation at the synapse has not N-end rule degradation, leads to impairment in spatial
been intensely investigated as a means of controlling memory in mice [46]. The NTAN1 amidase functions in
protein dynamics modulating neurotransmission strength. the N-end rule by deamidating N-terminal asparagine
In the last few years, a growing body of evidence from residues to aspartate [47]. N-terminal aspartate is then
Aplysia, C. elegans, Drosophila, rodent models, and bio- conjugated with arginine by aminoacyl-tRNA-Protein
chemical studies has begun to suggest that ubiquitin- transferase (ATE1) [48, 49]. The N-terminal arginine resi-
mediated degradation may provide a mechanism for due then acts as a primary destabilizing residue and
controlling protein abundance at the synapse [2–4, 7–10, directs degradation via association with the ubiquitin
14, 40]. In addition, the discovery that UPS misregulation ligase Ubr1. Based on results presented here, it is possi-
is a common trait among a subset of neurodegenerative ble that disruption of spatial memory in NTAN1 mutant
diseases [41–43] has bolstered recent study of the UPS mice may reflect a failure to degrade synaptic substrates
in mature neurons, particularly at synaptic connections. of the N-end rule, although specific synaptic substrates
Functional analyses testing the role of the UPS in neuro- have not yet been identified in vivo.
transmission are lacking, although it has recently been A specific native target of the UPS in the Drosophila
demonstrated that mouse mutations in a ubiquitin-spe- presynaptic NMJ terminal is DUNC-13 [14], a C1/C2
cific protease, Usp14, alter both central and peripheral domain protein critical for the determination of neuro-
synaptic transmission efficacy [44]. Very recently, the transmission strength [12, 13]. Acute application of lac-
activity-dependent regulation of protein degradation of tacystin, a drug that specifically inhibits proteolytic
postsynaptic proteins has been demonstrated biochem- cleavage by the proteasome [28], causes an approxi-
ically [11]. No study has directly investigated the role of mate doubling of DUNC-13 abundance within synaptic
local, UPS-dependent protein degradation in the acute boutons in 1 hr. Targeted presynaptic inhibition of pro-
modulation of synaptic transmission strength. The pres- teasome activity with dominant-negative proteasome sub-
ent study was aimed at asking whether the UPS func- units (UAS:DTS5 construct) confirms the pharmacologi-
tions locally at the synapse, whether the UPS targets cal result and further demonstrates that DUNC-13 is a
proteins for dynamic degradation in vivo at the synapse, presynaptic substrate of the proteasome. Immunopre-
cipitation of DUNC-13 from Drosophila heads revealsand whether UPS activity is important in acutely de-
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a higher molecular-weight band that crossreacts with some inhibition is the result of increased presynaptic
efficacy. Because mEJC amplitude remains consistent-ubiquitin antibodies, confirming that DUNC-13 is tar-
geted to the proteasome via ubiquitin attachment [14]. during lactacystin and epoxomicin treatments of ap-
proximately 1 hr, UPS-dependent modification of theThe acute regulation of DUNC-13 abundance by UPS-
dependent protein degradation rate is quite specific to postsynaptic receptor field does not occur at detectable
levels during this time period. Note, however, that thethis protein; other membrane, vesicular, and cytosolic
proteins in the presynaptic terminal do not change in UPS also regulates the postsynaptic receptor field (see
Zhao et al., this issue; [7–10]) and the synaptic architec-levels after 1 hr lactacystin treatment. This result some-
what contrasts to the recent report that postsynaptic ture field (see Zhao et al., this issue; [7–10]), on a longer
timescale (approximately 24 hr), indicating that proteinproteins of multiple classes are globally regulated by the
UPS [11]. This difference probably reflects the different degradation is critical at multiple levels of synaptic mod-
ulation. In the acute phase, however, UPS-dependenttimescale of these two studies (approximately 1 hr here,
compared to approximately 48 hr in [11]). Thus, the regulation of synaptic transmission must be driven
solely by rapid changes in the level of regulatory presyn-abundance of DUNC-13 is clearly dynamically regulated
by the UPS, whereas the set level of postsynaptic den- aptic protein(s). A possible mechanism arising from this
study is that local upregulation of DUNC-13 abundancesity proteins may be regulated via a slower process.
Regardless, the apparent specificity of the regulated at presynaptic sites drives increased synaptic vesicle
priming and subsequent fusion to elevate neurotrans-degradation pathway to DUNC-13 in our study must
be treated cautiously because investigation is severely mission. Nevertheless, because other presynaptic pro-
teins also interact with the UPS [7–10], it is likely that thelimited to a number of known presynaptic proteins with
available specific antibodies. UPS-dependent control of multiple presynaptic proteins
cooperatively modulates synaptic transmission.The identification of DUNC-13 as an acutely regulated
UPS substrate in the presynaptic terminal has important This study provides evidence that ubiquitin-depen-
dent proteasomal protein degradation functions locallyramifications for the modulation of neurotransmitter re-
lease. Members of the UNC-13 protein family are known at presynaptic sites to rapidly control levels of presynap-
tic proteins and suggests that regulation of protein deg-to be essential for synaptic vesicle priming in C. elegans,
Drosophila, and mice [50–52]. UNC-13 modulation radation rate represents a novel mechanism for control-
ling presynaptic efficacy on a similar, intermediate-rapiddownstream of G protein-coupled signal transduction
cascades actively regulates presynaptic efficacy and timescale (tens of minutes). Although strengthened
transmission correlates well with DUNC-13 accumula-neurotransmission strength [53, 54]. For example, pro-
gressive reduction of UNC-13 levels in C. elegans pro- tion over this time period, proving that DUNC-13 medi-
ates increased presynaptic function under these condi-gressively reduces synaptic transmission strength [52],
and presynaptic overexpression of MUNC-13-1 in Xeno- tions is a daunting task and will require further
investigation. This study makes apparent the necessitypus causes increased synaptic transmission [12]. Similar
secretion potentiation is caused by MUNC-13-1 overex- of identifying the ubiquitin ligases present at the syn-
apse and determining their cognate substrates. Morepression in chromaffin cells with regards to dense core
vesicle release [13]. These studies show that UNC-13 important will be the characterization of interactions be-
tween the UPS and its substrates at the synapse andacts as the limiting factor in the control of presynaptic
neurotransmitter release and indicate that the strength determining how these interactions may impact synap-
tic processes, including modulation of transmissionof neurotransmission may be controlled directly by the
levels of this protein. Thus, this known mechanism predicts strength downstream of regulatory factors and during
activity-dependent plasticity.that DUNC-13 accumulation caused by acute interference
with its regulated, UPS-dependent degradation may corre-
Experimental Procedureslate with increased synaptic transmission strength.
Inhibition of proteasome activity with either lactacys-
Drosophila Strainstin or epoxomicin for 1 hr causes a highly significant
The following transgenic Drosophila strains were used in this study:
approximately 50% average increase in synaptic trans- UAS, Ub-R-DHFRts-HA-EGFP; UAS, Ub-M-DHFRts-HA-EGFP; UAS,
mission amplitude at the Drosophila NMJ. Previous EGFP, and UAS, DTS5. All UAS constructs were expressed in the
studies have shown that the UPS is important for some nervous system under control of the pan-neuronal elav GAL4 driver
[56]. The wild-type strain Oregon-R (OR) was used as a control. Allforms of long-term synaptic plasticity; however, its role
electrophysiology, antibody staining, live imaging, and pharmaco-was shown to be at the transcriptional level in Aplysia
logical assays were performed on dissected mature third-instar lar-[55], not directly at the synapse. Importantly, therefore,
vae at the wandering stage.
when Aplysia synapses are acutely (1 hr) exposed to
proteasome inhibitors, they show a highly comparably Molecular Techniques
elevation in synaptic transmission strength (approxi- The Ub-R-DHFRts-Hemaglutanin (HA) and Ub-M-DHFRts-HA con-
mately 50%; see accompanying paper by Zhao et al., structs in pRc/CMV (Invitrogen Corp.) were a kind gift from Dr.
Fredric Le´vy [57]. Both constructs were PCR cloned into the EcoR1/pages 887–898 of this issue). Our data indicate that
Eag1 site of the Drosophila pUAST transformation vector. PUASTneither transcription nor translation is involved in the
was modified by digestion with Xba/Eag1 and ligation in a newmechanism in Drosophila; application of the transla-
polylinker with additional sites as follows: 5-CGGCCGGCTCGAGGtional inhibitor anisomycin does not block synaptic
AACTAGTCGGACCGCAGCTAGCGCCGGCCCTCAGGACGCGTCT
strengthening after acute proteasome inhibition. Direct GGTAACCGGGGTCCTAGGTCTAGA-3. The Enhanced Green Fluo-
electrophysiological investigation indicates that the rescent Protein (EGFP) coding sequence (CLONTECH Lab.) was
then subcloned into the Xba1/Spe1 site of the modified pUAST.heightened transmission strength caused by protea-
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All constructs were transformed according to standard Drosophila sured with the Imagequant program (Molecular Dynamics, Sun-
nyvale, CA), and the ratio of fluorescent labels was calculated fortransformation protocols [58].
each test condition. Mean ratios of test conditions were normalized
to controls. Statistical analyses were done with the Instat programWestern Analysis
(Graphpad Software, San Diego, CA).Adult flies expressing either R- or M-DHFRtsHA-EGFP were subject
to a 30 min heat shock at 35C or maintained at 18C. Heads were
Electrophysiologydissected away from the body and ground in glass tubes with glass
Larval dissections and recordings were made in standard Drosoph-pestles in 2.5 sample buffer containing 8M urea. Samples were
ila saline containing (in mM): 128 NaCl, 4 MgCl2, 2KCl, 0.4 Ca2Cl, 70boiled for 5 min at 95C, centrifuged at 14,000 rpm for 5 min, and
sucrose, and 5 HEPES. All recordings were made at 18C fromloaded onto a 4%–20% tris-glycine gradient gel (BIO-RAD). Proteins
ventral longitudinal muscle 6 in abdominal segments A3-A4 ofwere then immunobloted to PVDF membrane (BIO-RAD), and the
freshly dissected wandering third-instar larvae as previously de-membrane was blocked with 10% milk and 5% BSA. The membrane
scribed [60]. The segmental nerve was stimulated with a glass suc-was then probed with anti-HA (Roche) at a concentration of 1:500
tion electrode. Suprathreshold stimulation in the range of 2–5 V,in the presence of 5% milk. An anti-mouse IgG secondary antibody
which reflects approximately twice threshold, was applied in allconjugated to alkaline phosphatase was utilized at a concentration
experiments. Two-electrode voltage-clamp recordings of excitatoryof 1:1000 after washing of the primary antibody. Bands were visual-
junctional currents (EJCs) were made at a holding potential of 60ized with NBT and BCIP substrates (Gibco). For the E1 [15] and 20s
mV with an AxoClamp 2B amplifier (Axon Instruments, Burlingame,Westerns, the respective rabbit anti-human antibodies were used
CA). Miniature EJCs (mEJCs) were acquired from at least six animalsat 1:500. Protein for the E1 and 20s Westerns was extracted from
per genotype and consisted of at least 5 min of continuous re-Drosophila heads with SDS sample buffer (4M -mercaptoethanol,
cording. mEJC amplitude and frequency were analyzed with Mini10% glycerol, 3% SDS, 62.5 mM Tris) along with complete protease
Analysis software 3.0 (Jaejin Software).inhibitor. Blocking for the E1 Western was done with 10% milk/3%
Drug treatments were performed by, first, dissection of matureBSA, whereas only 3% BSA was used for the 20s Western. Goat anti-
third-instar larvae in 1.8 mM Ca2 standard saline. Proteasome inhi-rabbit-conjugated HRP secondary antibodies were used at 1:20,000.
bition experiments were done with 100 M lactacystin (Sigma) inSignals were detected with the Pierce SuperSignal Detection Kit.
saline or 125 M epoxomicin (Boston Biochem, Cambridge MA) in
DMSO, or DMSO alone as a control. Translation inhibition experi-Immunocytochemistry
ments were done with 40M anisomycin (Sigma) alone or coappliedAntibody staining was performed on mature (wandering) third-instar
together with 125 M epoxomicin. After incubation with any of theselarvae that were dissected in standard saline and fixed in 4% para-
reagents, preparations were washed thoroughly with 0.4 mM Ca2formaldehyde for 30 min. Fixed larvae were then blocked and perme-
bath. Saline was recorded prior to performance of electrophysiologi-abilized in PBS-Triton X-100 (0.1%) with BSA (0.2%). The following
cal measurements.antibodies were utilized for staining: -human ubiquitin-activating
enzyme (E1) (1:500), -human 20s proteasome (hurb) (1:500),
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